Jobs IRLDecoding DemocracyA Warmer WorldI've Always Wondered ...

Loading...

0:00
0% played
Stories Tagged as

Zepbound

How a weight loss drug's approval could affect insurance premiums

by Kimberly Adams
Nov 10, 2023
The FDA's approval of Eli Lilly's Zepbound could signal more insurers paying for the use of such drugs. Demand is great so the costs could be big and push up premiums.
Eli Lilly’s newly FDA-approved weight loss drug, Zepbound, is priced roughly 21% lower than competitor Novo Nordisk’s Wegovy.
Eli Lilly
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE